JENNIFER ALAMILLO: Open Payments
NPI 1235603713 · JOLIET, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,726 in 138 payments from 26 companies in 2025. Trend: 2023 $3,381 · 2024 $4,118 · 2025 $2,726
Food & beverage: $2,726
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $530 |
| Lilly USA, LLC | 11 | $210 |
| Phathom Pharmaceuticals, Inc. | 6 | $185 |
| AstraZeneca Pharmaceuticals LP | 10 | $185 |
| Axsome Therapeutics, Inc. | 7 | $173 |
| PFIZER INC. | 9 | $172 |
| Aimmune Therapeutics, Inc. | 14 | $155 |
| Teva Pharmaceuticals USA, Inc. | 7 | $148 |
| GlaxoSmithKline, LLC. | 6 | $141 |
| Otsuka America Pharmaceutical, Inc. | 6 | $126 |
Products named: QULIPTA, MOUNJARO, VOQUEZNA, ZENPEP, AUSTEDO XR, NURTEC ODT, REXULTI, TRELEGY ELLIPTA.
Industry payments across IL — which companies pay providers there.
